Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 187
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
2/15/2006
1.
Phase II/III Master Protocol for Chemotherapy with DTIC/ACT-D vs CACP/VBL/BLEO vs Phase II Agent with or without Prophylactic Cranial Radiotherapy for Disseminated Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
18 and over
NCI
SWOG-8107
SWOG-8107
Last Modified:
8/10/2007
2.
Phase II/III Pilot Combination Chemotherapy and Radiotherapy for Previously Untreated Childhood ALL with Poor Prognosis
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Completed
under 21
NCI
CCG-192P
Last Modified:
4/5/2007
3.
Phase II/III Study of L-PAM or IPP/Mesna, Followed by Conventional Chemotherapy with VCR/CTX/ADR plus CTX/VCR/ACT-D/ADR, Surgery, and Radiotherapy, for Stage IIB/IIC/IIIA/IIIB Rhabdomyosarcoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Completed
under 18
NCI
SJCRH-RMS-V
NCI-T86-0152D, T86-0152
4.
Phase II-III Chemotherapy with ACT-D/5-FU/CTX and/or Radiotherapy for Malignant Tumors of the Ovarian Stroma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Completed
no age specified
NCI
GOG-14
Last Modified:
6/28/2006
 
First Published:
12/1/1994
5.
Phase III Study of Multimodality Therapy Based on Prior Therapy and Histology in Patients With Relapsed Wilms' Tumor
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
21 and under at diagnosis
NCI
COG-Q9402
NWTS-Q9402, CCG-4942, POG-9444, INT-0152, NWTS-5/R, NCT00002610, Q9402
Last Modified:
9/22/2008
 
First Published:
12/1/1994
6.
Phase III Multimodality Therapy Based on Histology, Stage, Age, and Tumor Size in Children With Wilms' Tumor, Clear Cell Sarcoma of the Kidney, or Rhabdoid Tumors of the Kidney
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
Under 16
NCI
COG-Q9401
NWTS-Q9401, CCG-4941, POG-9440, INT-0150, NWTS-5, NCT00002611, Q9401
Last Modified:
8/10/2006
7.
Phase III Randomized Study of Induction With the ALL-2 Regimen (Cytarabine and High-Dose Mitoxantrone Based) Versus the L-20 Regimen (Vincristine and Prednisone Based) in Adults With Acute Lymphoblastic Malignancy: The ALL-4 Protocol
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
Other
MSKCC-96015A1
NCI-V96-0881, NCT00002766
Last Modified:
8/10/2006
 
First Published:
12/1/1996
8.
Phase III Study of Surgery Followed By Chemotherapy in Patients With Nonmetastatic Soft Tissue Sarcoma With Randomization to 3-Drug Versus 6-Drug Continuation Therapy in Patients With High-Risk Chemosensitive Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
Under 18
Other
SIOP-MMT-95
EU-96035, NCT00002898
Last Modified:
10/22/2007
 
First Published:
6/1/1997
9.
Phase III Study of Dactinomycin and Vincristine With or Without Cyclophosphamide and/or Radiotherapy in Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma of Embryonal or Botryoid Subtype
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
Under 50
NCI
COG-D9602
CCG-D9602, POG-D9602, IRS-D9602, D9602, NCT00002995
Last Modified:
6/11/2008
 
First Published:
2/1/1999
10.
Phase III Randomized Study of Methotrexate Versus Dactinomycin in Patients With Low-Risk Gestational Trophoblastic Neoplasia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
Not specified
NCI
GOG-174
ECOG-G174, GOG-0174, NCT00003702
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute